Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNYSE:AGLNASDAQ:FLGTNASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$113.01-0.7%$109.13$88.96▼$136.72$2.09B0.81170,573 shs154,746 shsAGLAgilon Health$2.16+2.1%$2.96$1.50▼$7.73$873.44M0.144.95 million shs2.50 million shsFLGTFulgent Genetics$19.33-1.0%$19.85$14.57▼$25.11$594.56M1.06284,730 shs251,732 shsPGNYProgyny$20.79-0.9%$21.85$13.39▼$30.42$1.80B1.321.70 million shs1.11 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-0.69%-1.25%+0.76%+18.95%-4.59%AGLAgilon Health+1.89%-1.33%-3.15%-51.79%-66.95%FLGTFulgent Genetics-1.02%-7.69%-4.83%+13.37%-4.64%PGNYProgyny-0.91%-1.28%+1.32%-3.26%-19.61%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.781 of 5 stars3.62.00.05.02.82.52.5AGLAgilon Health3.3557 of 5 stars4.14.00.00.03.80.00.6FLGTFulgent Genetics4.0689 of 5 stars2.34.00.04.12.83.30.6PGNYProgyny1.8153 of 5 stars2.21.00.00.03.22.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5726.16% UpsideAGLAgilon Health 2.17Hold$4.79122.07% UpsideFLGTFulgent Genetics 2.50Moderate Buy$24.0024.16% UpsidePGNYProgyny 2.42Hold$23.4512.82% UpsideCurrent Analyst Ratings BreakdownLatest FLGT, PGNY, ADUS, and AGL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/13/2025AGLAgilon HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.005/8/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.005/8/2025AGLAgilon HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.50 ➝ $5.005/6/2025FLGTFulgent GeneticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$16.00 ➝ $23.005/5/2025FLGTFulgent GeneticsRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$24.00 ➝ $25.004/28/2025AGLAgilon HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/25/2025AGLAgilon HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.25 ➝ $5.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.80$5.35 per share21.11$53.52 per share2.11AGLAgilon Health$6.06B0.15N/AN/A$1.14 per share1.89FLGTFulgent Genetics$283.47M2.08N/AN/A$36.92 per share0.52PGNYProgyny$1.17B1.53$0.34 per share60.79$4.96 per share4.19Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.5121.081.616.52%9.23%6.96%8/4/2025 (Estimated)AGLAgilon Health-$260.15M-$0.59N/AN/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)FLGTFulgent Genetics-$42.71M-$1.33N/AN/AN/A-13.94%-2.19%-2.02%8/1/2025 (Estimated)PGNYProgyny$54.34M$0.5736.4731.982.214.33%10.90%7.20%8/5/2025 (Estimated)Latest FLGT, PGNY, ADUS, and AGL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025AGLAgilon Health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million5/2/2025Q1 2025FLGTFulgent Genetics-$0.18$0.04+$0.22-$0.37$71.26 million$73.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAGLAgilon HealthN/AN/AN/AN/AN/AFLGTFulgent GeneticsN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74AGLAgilon HealthN/A1.201.20FLGTFulgent GeneticsN/A6.326.32PGNYProgynyN/A2.392.39Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AGLAgilon HealthN/AFLGTFulgent Genetics48.06%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%AGLAgilon Health3.57%FLGTFulgent Genetics33.11%PGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableAGLAgilon Health1,076413.95 million399.17 millionNot OptionableFLGTFulgent Genetics1,31330.44 million20.36 millionOptionablePGNYProgyny31085.72 million77.66 millionOptionableFLGT, PGNY, ADUS, and AGL HeadlinesRecent News About These CompaniesProgyny Earns Relative Strength Rating UpgradeJune 23 at 1:45 PM | msn.comProgyny (PGNY) Soared on Expanding Client Base and Improving Utilization TrendsJune 18, 2025 | msn.comFort Washington Investment Advisors Inc. OH Reduces Stake in Progyny, Inc. (NASDAQ:PGNY)June 13, 2025 | marketbeat.comGAMMA Investing LLC Acquires 118,556 Shares of Progyny, Inc. (NASDAQ:PGNY)June 13, 2025 | marketbeat.comCheryl Scott Sells 2,675 Shares of Progyny, Inc. (NASDAQ:PGNY) StockJune 12, 2025 | marketbeat.comProgyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be ImpressedJune 10, 2025 | msn.comProgyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building SolutionJune 10, 2025 | finance.yahoo.comProgyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building SolutionJune 10, 2025 | globenewswire.comHere’s Why Progyny (PGNY) Rebounded in Q1June 9, 2025 | msn.comOlstein Capital Management L.P. Buys New Shares in Progyny, Inc. (NASDAQ:PGNY)June 9, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Acquired by NBC Securities Inc.June 6, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY)June 5, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Stock Position Lessened by Wellington Management Group LLPJune 4, 2025 | marketbeat.comLeibman Financial Services Inc. Sells 18,076 Shares of Progyny, Inc. (NASDAQ:PGNY)June 3, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of "Hold" by BrokeragesJune 3, 2025 | marketbeat.comMackenzie Financial Corp Boosts Stock Position in Progyny, Inc. (NASDAQ:PGNY)June 1, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Purchased by Nuveen Asset Management LLCJune 1, 2025 | marketbeat.comProgyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of DirectorsMay 29, 2025 | globenewswire.comProgyny’s SWOT analysis: fertility benefits firm faces growth challengesMay 29, 2025 | investing.comInsider Decision Unfolding At Progyny: Elizabeth Bierbower Exercises Options, Resulting In $0May 29, 2025 | benzinga.comMajor Update: DEBRA MORRIS At Progyny Exercises Options, Realizing $0May 29, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeFLGT, PGNY, ADUS, and AGL Company DescriptionsAddus HomeCare NASDAQ:ADUS$113.01 -0.78 (-0.69%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$113.04 +0.02 (+0.02%) As of 06/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Agilon Health NYSE:AGL$2.15 +0.05 (+2.13%) Closing price 06/23/2025 03:59 PM EasternExtended Trading$2.16 +0.01 (+0.42%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Fulgent Genetics NASDAQ:FLGT$19.33 -0.20 (-1.02%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$19.34 +0.01 (+0.07%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.Progyny NASDAQ:PGNY$20.79 -0.19 (-0.91%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$21.20 +0.41 (+1.97%) As of 06:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
